Benzinga Logo
My account
QQQ
–%
DIA
–%
SPY
–%
TLT
–%
GLD
–%
BTC/USD
–%
Contribute
Sign in
Benzinga Logo
My Stocks
Tools
Calendars
Earnings Calendar
IPO Calendar
Guidance Calendar
FDA Calendar
Dividend Calendar
Stock Split Calendar
Conference Call Calendar
Economic Calendar
Trade Ideas
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Premium
QQQ
––%
DIA
––%
SPY
––%
TLT
––%
GLD
––%
BTC/USD
––%
Range
1.05 - 1.14
Vol / Avg.
2.1M/6.7M
Div / Yield
-
52 Wk
0.85 - 4.99
Mkt Cap
186M
Payout Ratio
-
Open
1.07
P/E
-
EPS
-0.03
Shares
172.2M
Outstanding
172.2M
Total Float
124.5M
Benzinga - Aug 24, 2021, 7:06AM
Benzinga - Aug 10, 2021, 6:46AM
Benzinga - Jul 26, 2021, 1:06PM
Benzinga - Jul 26, 2021, 10:55AM
Benzinga - Jul 26, 2021, 8:20AM
Benzinga - Jul 26, 2021, 8:06AM
Benzinga - Jul 22, 2021, 10:48AM
Benzinga - Jun 11, 2021, 7:26AM
Benzinga - Jun 10, 2021, 4:52PM
Benzinga - Jun 10, 2021, 4:20PM
Benzinga - Jun 10, 2021, 4:18PM
Benzinga - Jun 10, 2021, 1:19PM
Benzinga - May 18, 2021, 11:01AM
Benzinga - May 13, 2021, 9:07AM
Benzinga - Apr 1, 2021, 8:16AM
load more
Sector: Health Care.Industry: Biotechnology
Tyme Technologies Inc is the U.S based clinical-stage biotechnology company. The company is focused on the development and commercialization of targeted cancer therapeutics with a broad range of oncology indications for humans. SM 88, its proprietary drug candidate compound, is a novel compound that has the potential to alter defenses to oxidative stress and increase free radical availability to the cancer cell. The company is currently conducting a Phase II trial in prostate cancer.

Earnings

see more
Q2 2022Est.ActualSurprise
EPS
(EXPECTED)2021-11-11
REV
Q1 2022Est.ActualSurprise
EPS-0.030
REV5.000M0-5.000M

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Related Companies

TickerCompanyChg %Mkt Cap
TYMETyme Technologies2.86%186M

Tyme Technologies Questions & Anwsers

Q

How do I buy Tyme Technologies (TYME) stock?

A

You can purchase shares of Tyme Technologies (NASDAQ: TYME) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Tyme Technologies's (TYME) competitors?

A

Other companies in Tyme Technologies’s space includes: HOOKIPA Pharma (NASDAQ:HOOK), T2 Biosystems (NASDAQ:TTOO), Evaxion Biotech (NASDAQ:EVAX), Sesen Bio (NASDAQ:SESN) and Gemini Therapeutics (NASDAQ:GMTX).

Q

What is the target price for Tyme Technologies (TYME) stock?

A

The latest price target for Tyme Technologies (NASDAQ: TYME) was reported by Canaccord Genuity on January 4, 2018. The analyst firm set a price target for 10.00 expecting TYME to rise to within 12 months (a possible 825.93% upside). 0 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Tyme Technologies (TYME)?

A

The stock price for Tyme Technologies (NASDAQ: TYME) is $1.08 last updated Fri Sep 24 2021 20:00:03 GMT+0000 (Coordinated Universal Time).

Q

Does Tyme Technologies (TYME) pay a dividend?

A

There are no upcoming dividends for Tyme Technologies.

Q

When is Tyme Technologies (NASDAQ:TYME) reporting earnings?

A
Tyme Technologies’s Q2 earnings are confirmed for after-market on November 11, 2021.
Q

Is Tyme Technologies (TYME) going to split?

A

There is no upcoming split for Tyme Technologies.

Q

What sector and industry does Tyme Technologies (TYME) operate in?

A

Tyme Technologies is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.